Marc Frahm

Stock Analyst at TD Cowen

(0)
# 4991
Out of 5,253 analysts
23
Total ratings
7.69%
Success rate
-33.88%
Average return
Main Sectors:
Top Industries:
16 Stocks
Name Action Price Target Current % Upside Ratings Updated
Sana Biotechnology
Upgrades: Buy
n/a
n/a n/a 2 Jan 8, 2025
Theravance Biopharma
Maintains: Hold
10 9
9.74 -7.6% 3 Aug 6, 2024
Incyte
Maintains: Buy
88 80
73.52 8.81% 3 May 1, 2024
Cullinan Oncology
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Jun 15, 2023
DICE Therapeutics
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Mar 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 1 Jan 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
36
n/a n/a 2 Nov 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Nov 16, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Aug 23, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Jul 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Jul 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Jun 21, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 2 Jun 3, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Mar 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Aug 18, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Feb 24, 2020